GESTIÓN EN SALUD PÚBLICA: Patient-Focused Drug Development: Methods to Identify What Is Important to Patients | FDA

martes, 1 de marzo de 2022

Patient-Focused Drug Development: Methods to Identify What Is Important to Patients | FDA

Patient-Focused Drug Development: Methods to Identify What Is Important to Patients | FDA

No hay comentarios:

Publicar un comentario

Suscribirse a: Enviar comentarios (Atom)